Suvretta Capital Management, LLC Protagonist Therapeutics, Inc Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$21.79 - $32.15 $664,595 - $980,575
30,500 New
30,500 $882,000
Q3 2023

Nov 14, 2023
BUY
$16.68 - $23.66 $453,112 - $642,723
27,165 Added 33.48%
108,308 $1.81 Million
Q2 2023

Aug 14, 2023
BUY
$18.02 - $29.36 $1.46 Million - $2.38 Million
81,143 New
81,143 $2.24 Million

Others Institutions Holding PTGX

# of Institutions
248
Shares Held
56.7M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.93B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email